Table of Content
- Executive Summary
- Industry Introduction, including Taxonomy and Market Definition
- Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- Global Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
- Pricing Analysis
- Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035
- Product
- Medical Condition
- Application
- End User
- By Product
- Free Radical Trapping Agents (Antioxidants)
- Glutamate Antagonists (Anti-Excitotoxic Agents)
- Apoptosis Inhibitors
- Anti-inflammatory Agents
- Neurotrophic Factors (NTFs)
- Other Products
- By Medical Condition
- Alzheimer's Disease
- Dementia
- Epilepsy
- Multiple Sclerosis
- By Application
- Prevention
- Treatment
- By End User
- Hospitals
- Clinics
- Others
- By Region
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia Pacific
- Middle East & Africa
- North America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Latin America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Western Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Eastern Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- East Asia Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- South Asia Pacific Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Middle East & Africa Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, by Key Segments and Countries
- Sales Forecast to 2035 by Product, Medical Condition, Application, and End User for 30 Countries
- Competitive Assessment, Company Share Analysis by Key Players, and Competition Dashboard
- Company Profile
- Allergan PLC
- Daiichi Sankyo Co., Ltd.
- Astrocyte Pharmaceuticals Inc.
- AstraZeneca PLC
- Biogen, Inc.
- Novartis International AG
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Teva Pharmaceutical Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
